Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Trevi Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 175K | Feb 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TRVI | Trevi Therapeutics, Inc. | Feb 15, 2024 | 1 | $0 | 4 | Feb 16, 2024 | Chief Medical Officer |
TRVI | Trevi Therapeutics, Inc. | Nov 14, 2022 | 1 | $0 | 4 | Nov 14, 2022 | Chief Medical Officer |
TRVI | Trevi Therapeutics, Inc. | Nov 14, 2022 | 0 | $0 | 3 | Nov 14, 2022 | Chief Medical Officer |